The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group.
about
Bipolar disorder and alcohol use disorder: a reviewOpioid antagonists for alcohol dependenceOpioid antagonists for alcohol dependenceUpdate on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Naltrexone long-acting formulation in the treatment of alcohol dependence.Opioid antagonists for alcohol dependence.New methods of treatment efficacy research: bridging clinical research and clinical practice.Potent inhibition of alcohol self-administration in alcohol-preferring rats by a κ-opioid receptor antagonistOpioid dependence treatment: options in pharmacotherapy.Substance abuse in older people.Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation.Opiate antagonists in children and adolescents.Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyDoes naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence.Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.Iatrogenic effects of psychosocial interventions for substance use disorders: prevalence, predictors, prevention.Opioid antagonists in the treatment of alcohol dependence.The pharmacotherapy of alcohol dependence: a state of the art review.Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose.Naltrexone for the management of alcohol dependence.Inhibitory pathways and the inhibition of luteinizing hormone-releasing hormone release by alcoholBridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatmentPharmacological enhancement of naltrexone treatment for opioid dependence: a reviewDifferential effects of naltrexone on cardiac, subjective and behavioural reactions to acute ethanol intoxicationImpact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study.Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.Pharmacotherapy of alcohol use disorders.Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.A pilot study of naltrexone and BASICS for heavy drinking young adults.Long-acting injectable naltrexone for the treatment of alcohol dependence.Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trialCombining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.The novel micro-opioid receptor antagonist, [N-allyl-Dmt(1)]endomorphin-2, attenuates the enhancement of GABAergic neurotransmission by ethanol.The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.Pharmacoprophylaxis of alcohol dependence: Review and update Part I: Pharmacology.
P2860
Q22252584-A36DD68B-A1F4-446D-8E64-59601060E51BQ24235797-AFA5233B-6A18-49F8-9720-C32B7A50BB33Q24244900-D9011840-64D0-4A1F-A2B7-D8088626FB55Q30440516-28C1B2E6-5D9E-459E-95DE-CDC1B73336A6Q30441807-A0C64F9B-6769-40E1-A0A6-9B55BF059573Q31083745-0379FDA6-F3BB-4988-B30E-5B6AED9684F7Q33669425-E6CD2A2E-31D7-42B5-A94F-D9871AF3DFF8Q33750830-4DDCB465-7B95-431A-9046-76698DBF2262Q33868638-95C7B28F-8C34-46CC-8C2D-5220D11E5D1EQ34020869-325F0EE0-A824-42DC-A8E2-AB583845BD3AQ34043568-7C4A6B9F-E555-45AD-A933-6A33A5530163Q34120061-47458220-5B74-4980-92D4-9C953195348EQ34135756-AA50F1FB-F18D-496E-A383-78748F71543BQ34248568-83F136A2-877A-4401-8DE3-61652C522675Q34327297-434C9394-155F-4EFF-B277-28636D628FEDQ34357213-699E846C-F80E-409B-8239-CDA79470D3EFQ34413363-891B419E-8225-45DF-8317-43806BC15DF6Q34438002-D3675D55-B2EB-413B-81CF-3062ED4A4741Q34543952-B388DBDC-12CF-4376-B2F8-377F048864F5Q34619209-D495BB8D-53D9-4C27-9D82-A39FCF123643Q34656944-2A012405-0890-4896-B786-3CF988388774Q35055190-7B1ADD7F-D3BC-42F4-B522-7FD086B83392Q35074748-7B17362F-E9F8-4AFB-994F-30CF679E74CDQ35084340-FC6EBFE0-2694-45DA-B720-3B7A43FA7AEBQ35129315-69C9C9C5-C3E5-423D-842A-5097A480CF0AQ35220474-05169E14-D789-4382-9CE1-EA8F90B8B49DQ35225923-CBB80E1F-234D-4F0C-824D-83080FC2D097Q35566908-BF6CF14D-6C62-4CC6-906A-26B47C0F42F5Q36223647-26C6FAC6-8C9F-49D5-A45B-8C9F034F84A6Q36263819-2E1DCE93-7455-4F60-A9A6-8009054A8223Q36311029-996323DA-50ED-4E38-9196-B763ADC43ECEQ36461774-F27EA5BC-FF52-4B78-B638-971C114B9430Q36939060-ACEC0B8E-5CDB-421B-B4BA-C9353B1CB61FQ36972683-9E3A1C3A-7C52-4806-9130-FDA792BB59A0Q37179217-9E609D52-3B97-48C1-9ECA-E673FEE03A39Q37227488-1E399E48-8CCB-4C83-8072-4A7EED9F4234Q37267741-2ABF5175-4FE2-4F1A-8F2C-4F6712BD9F8DQ37300059-D01FFDC3-17C2-4F0A-8A80-F5BD23ACC5F5Q37392393-43227E4F-9475-4BAD-9FC8-9824F00978AEQ37773792-3A82F2EE-C663-4584-8985-FF603440A109
P2860
The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The safety profile of naltrexo ...... Naltrexone Usage Study Group.
@en
The safety profile of naltrexo ...... Naltrexone Usage Study Group.
@nl
type
label
The safety profile of naltrexo ...... Naltrexone Usage Study Group.
@en
The safety profile of naltrexo ...... Naltrexone Usage Study Group.
@nl
prefLabel
The safety profile of naltrexo ...... Naltrexone Usage Study Group.
@en
The safety profile of naltrexo ...... Naltrexone Usage Study Group.
@nl
P2093
P1433
P1476
The safety profile of naltrexo ...... Naltrexone Usage Study Group.
@en
P2093
Faulkner EB
Labriola DF
P304
P356
10.1001/ARCHPSYC.1997.01830240090013
P407
P577
1997-12-01T00:00:00Z